Lorelco: Uses, Dosage & Side Effects Guide

Introduction

Lorelco, also known as Probucol” target=”_blank”> Probucol , is a prescription medication used to treat high cholesterol levels, particularly in patients with coronary artery disease. As an antihyperlipidemic drug, Lorelco helps lower low-density lipoprotein (LDL) cholesterol, often referred to as “bad” cholesterol, which can contribute to the development of cardiovascular diseases.

Chemical Composition

Probucol, the active ingredient in Lorelco, has the chemical formula C ₃₁H ₄₈O ₂S ₂. Its CAS Number is 23288-49-5, and it is also known by the synonyms DH 581, NSC 86225, and NSC 652160. The chemical structure of Probucol consists of two phenol rings connected by a sulfur-containing bridge.

Indications and Clinical Use

Lorelco is primarily indicated for the treatment of hypercholesterolemia and high cholesterol levels, particularly in patients with coronary artery disease. It is often used as an adjunct therapy to diet, as recommended by the American Heart Association (AHA) guidelines.

Mechanism of Action

Lorelco works by inhibiting the oxidation of LDL cholesterol, which is a key step in the development of atherosclerosis. By reducing the oxidation of LDL cholesterol, Lorelco helps prevent the formation of plaques in the arteries, thereby lowering the risk of cardiovascular events.

Drug Class

Lorelco belongs to the class of medications known as miscellaneous antihyperlipidemic agents. These drugs work to lower cholesterol levels through various mechanisms that differ from those of other common cholesterol-lowering medications, such as statins.

Usage and Dosage

Lorelco is available in two dosage forms and strengths: LORELCO 500 Pill (White Oval) and LORELCO 250 Pill (White Round). The usual starting dose is 500 mg twice daily, with a maximum daily dose of 1000 mg. Dosage adjustments may be necessary based on individual patient response and tolerability.

Effectiveness

Clinical studies have shown that Lorelco can effectively lower LDL cholesterol levels by up to 20-30%. However, it may also slightly decrease high-density lipoprotein (HDL) cholesterol, or “good” cholesterol, and has limited effects on triglyceride levels. The overall impact on cardiovascular risk reduction is less significant compared to other cholesterol-lowering medications, such as statins.

Side Effects and Risks

Common side effects of Lorelco include gastrointestinal disturbances, such as diarrhea, nausea, and abdominal pain. More serious side effects may include QT prolongation, ventricular arrhythmias, and an increased risk of cardiovascular events in some patients. Lorelco should be used with caution in patients with pre-existing heart conditions or those taking other medications that may affect heart rhythm.

Drug Interactions

Lorelco may interact with other medications, including blood thinners, digoxin, and certain antibiotics. Patients should inform their healthcare provider about all medications they are taking before starting Lorelco. Additionally, nurses should be aware of the potential interactions and monitor patients closely for any adverse effects.

International Usage

Lorelco is available under various brand names in different countries, including Bifenabid, Lesterol, Lurselle, Panesclerina, Sinlestal, and Superlipid. Availability and specific indications may vary depending on local regulatory guidelines.

Research and Studies

Numerous clinical trials and studies have investigated the efficacy and safety of Lorelco in treating high cholesterol levels. A randomized, double-blind, placebo-controlled study published in the American Journal of Cardiology found that Lorelco significantly reduced LDL cholesterol levels compared to placebo, but also slightly decreased HDL cholesterol levels. Ongoing research continues to explore the potential benefits and risks of Lorelco in various patient populations.

Regulatory Information

Lorelco was first approved by the U.S. Food and Drug Administration (FDA) in 1977 for the treatment of hypercholesterolemia. However, its use has declined in recent years due to the availability of more effective and safer cholesterol-lowering medications, such as statins. In some countries, Lorelco has been withdrawn from the market or has limited availability.

Market and Manufacture

Lorelco was originally developed and manufactured by Merrell Dow Pharmaceuticals, which later became part of Sanofi-Aventis. Generic versions of Probucol are now available from various manufacturers worldwide.

Miscellaneous

In addition to its cholesterol-lowering properties, Lorelco has also been investigated for its potential antioxidant effects. Some studies suggest that Probucol may have protective effects against oxidative stress and inflammation, which are involved in the development of various diseases, including cardiovascular disorders and certain types of cancer. However, more research is needed to fully understand these potential benefits.